[2-methyl-4-[2-methyl-4-(2-methylbutan-2-yloxycarbonyloxy)pentan-2-yl]oxypentan-2-yl] 2,2,2-trifluoroacetate
C20H35F3O6 — CID 139436782
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-methyl-4-[2-methyl-4-(2-methylbutan-2-yloxycarbonyloxy)pentan-2-yl]oxypentan-2-yl] 2,2,2-trifluoroacetate
[2-methyl-4-[2-methyl-4-(2-methylbutan-2-yloxycarbonyloxy)pentan-2-yl]oxypentan-2-yl] 2,2,2-trifluoroacetate (PubChem CID 139436782) has the molecular formula C20H35F3O6 and a molecular weight of 428.49 g/mol. Its IUPAC name is [2-methyl-4-[2-methyl-4-(2-methylbutan-2-yloxycarbonyloxy)pentan-2-yl]oxypentan-2-yl] 2,2,2-trifluoroacetate.
Molecular Properties
| Compound Name | [2-methyl-4-[2-methyl-4-(2-methylbutan-2-yloxycarbonyloxy)pentan-2-yl]oxypentan-2-yl] 2,2,2-trifluoroacetate |
|---|---|
| PubChem CID | 139436782 |
| Molecular Formula | C20H35F3O6 |
| Molecular Weight | 428.49 g/mol |
| Exact Mass | 428.24 |
| IUPAC Name | [2-methyl-4-[2-methyl-4-(2-methylbutan-2-yloxycarbonyloxy)pentan-2-yl]oxypentan-2-yl] 2,2,2-trifluoroacetate |
| SMILES | CCC(C)(C)OC(=O)OC(C)CC(C)(C)OC(C)CC(C)(C)OC(=O)C(F)(F)F |
| InChI | InChI=1S/C20H35F3O6/c1-10-17(4,5)29-16(25)26-13(2)11-18(6,7)27-14(3)12-19(8,9)28-15(24)20(21,22)23/h13-14H,10-12H2,1-9H3 |
| InChIKey | WUVKPSCHOYUCRH-UHFFFAOYSA-N |
| XLogP | 5.56 |
| TPSA | 71.06 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.49 |
| LogP ≤ 5 | 5.56 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139436782 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.